Co-prescribing of medications with anticholinergic properties to those using cholinesterase inhibitors for dementia

Abstract

Medications with anticholinergic (AC) prop- erties have adverse effects on cognition and many guidelines recommend avoiding them in older adults. Theoretically they could negate benefits of cholinesterase inhibitor (CI) treatment in patients dementia patients, although there is inadequate evidence to date.